Table 2:

Association of measures of continuous imaging features with variant histone H3–altered tumors

Imaging MetricH3-3AH3C2/3P Valuea
No.Median (Range)No.Median (Range)
ADC total (×10–6 mm2/s)
 Mean461227.51 (538.06–1710.88)91586.56 (1224.37–1797.58).001
 Median461185 (532–1755)91654 (1215–1842).001
 Mode461168.14 (450.92–1902.53)91703.88 (1263.52–1961.24).001
 Skewness380.91 (−0.49–2.16)9–0.20 (−0.89–0.88).003
 Kurtosis381.57 (−0.60–9.71)90.40 (−0.78–1.79).002
ADC_enhancement (×10–6 mm2/s)
 Mean331138.81 (689.44–1509.96)71390.54 (1033.58–1898.26).004
 Median331085 (667–1532)71364 (995–1890).003
 Mode331012.56 (577.86–1617.56)71393.38 (966.31–1746.86).002
 Skewness311.27 (−0.56–2.82)70.52 (−0.71–2.61).1
 Kurtosis312.08 (−0.94–13.03)70.85 (−0.84–9.09).3
FLAIR/T2/T1 PG volume (×103 mm3)
 FLAIR/T24435.75 (7.97–77.53)1041.10 (22.84–77.57).2
 Enhancing321.90 (0.07–14.10)95.04 (0.04–8.25).6
  • a Wilcoxon rank-sum test.